Joint HOVON-50/GMMG-HD3 randomized trial on the effect of thalidomide as part of a high-dose therapy regimen and as maintenance treatment for newly diagnosed myeloma patients

Translated title of the contribution: Joint HOVON-50/GMMG-HD3 randomized trial on the effect of thalidomide as part of a high-dose therapy regimen and as maintenance treatment for newly diagnosed myeloma patients

H. Goldschmidt, P. Sonneveld, T.W. Cremer, B. van der Holt, I. Westveer, I. Breitkreutz, A. Benner, A. Glasmacher, I.G. Schmidt-Wolf, H. Martin, D. Hoelzer, A.D. Ho, H.M. Lokhorst

Research output: Contribution to journalArticleAcademicpeer-review

Translated title of the contributionJoint HOVON-50/GMMG-HD3 randomized trial on the effect of thalidomide as part of a high-dose therapy regimen and as maintenance treatment for newly diagnosed myeloma patients
Original languageUndefined/Unknown
Pages (from-to)654-659
Number of pages6
JournalAnnals of Hematology
Volume82
Publication statusPublished - 2003

Cite this